Oracle acquires phase forward
Web“Phase Forward brings outstanding products and employees with significant expertise to Oracle that will help enable the delivery of personalized medicine and value-based healthcare.” “Deployed in over 10,000 clinical trials, Phase Forward’s software has been used successfully by hundreds of customers to accelerate innovation in drug ... WebApr 20, 2010 · Phase Forward Phase Forward is a provider of integrated data collection and data management solutions for clinical trials and drug safety. Acquiring Organization: Oracle Oracle is an integrated cloud application and platform services that sells a range of enterprise information technology solutions. Announced Date Apr 20, 2010
Oracle acquires phase forward
Did you know?
WebOracle acquires Phase Forward for its pharmacovigilance and clinical R&D capabilities, bringing Empirica into the Oracle product family. 2010 Groundbreaking new Argus … WebOct 17, 2024 · The deal would represent Oracle's fifth acquisition this year, though Oracle's acquisitions have not generally been in the healthcare sector. The last significant health sciences companies...
WebApr 15, 2010 · Oracle said Friday it will acquire Phase Forward, a healthcare and life sciences software provider, for $685 million. Oracle, which is intensely focused on vertical …
WebApr 20, 2010 · Phase Forward Phase Forward is a provider of integrated data collection and data management solutions for clinical trials and drug safety. Acquiring Organization: … WebApr 16, 2010 · Enterprise giant Oracle will acquire healthcare software firm Phase Forward for $685 million. Of course, this is small change compared to Oracle’s $7.4 billion acquisition of Sun...
WebApr 12, 2024 · Shares of ORCL stock opened at $93.97 on Wednesday. The company's fifty day simple moving average is $88.75 and its 200-day simple moving average is $81.83. Oracle Co. has a 52 week low of $60.78 and a 52 week high of $96.08. The company has a market cap of $253.70 billion, a PE ratio of 31.01, a P/E/G ratio of 2.99 and a beta of 1.00.
WebOracle announced has agreed to acquire Phase Forward, a leading provider of applications for life sciences companies and healthcare providers, through a cash merger for US$ … fishing rod blanks clearanceWebSep 5, 2008 · Phase Forward estimates the current IRT market to be between $200 and $250 million, and believes that the addition of an IRT offering will present significant cross-selling opportunities by enabling Phase Forward to offer both new and existing EDC customers an expanded product offering. fishing rod blanks for sale australiaWebApr 16, 2010 · As part of the deal with Phase Forward, Oracle will acquire all of the company’s employees and management. At the end of 2009, Phase Forward had 939 … fishing rod blank manufacturers in usaWebOracle (NASDAQ:ORCL) is reportedly acquiring Phase Forward (NASDAQ:PFWD) for $17 per share, or approximately $685 million. The price represents a 30% premium... fishing rod blanks uk onlyWebExpands Oracle's Solutions for the Life Sciences and Healthcare Industries Redwood Shores, Calif. - April 16, 2010 Oracle announced today that it has agreed to acquire Phase … fishing rod bootsWebPhase Forward is a leading provider of integrated data collection and data management solutions for clinical trials and drug safety. Our award-winning technology and global services are designed ... cancel foremost insurance policyhttp://test.pharmabiz.com/news/oracle-to-acquire-phase-forward-55932 cancel for any reason cfar